Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial).

Konstantinos PapamichaelVipul JairathGuangyong ZouBenjamin CohenTimothy RitterBruce SandsCorey SiegelJohn ValentineMichelle SmithNiels Vande CasteeleMarla DubinskyAdam Cheifetz

Published in: BMJ open (2022)

NCT04835506.

Keyphrases

study protocol
open label
clinical trial
phase iii
phase ii
randomized controlled trial
healthcare
palliative care
quality improvement
double blind
phase ii study
ulcerative colitis
radiation therapy
chronic pain
placebo controlled